Sequantrix
AI-driven development of fibrosis therapies based on single-cell data.
About Sequantrix
RWTH spin-off that applies AI methods to a large multimodal single-cell database to identify new antifibrotic targets, with a focus on fibrosis in kidneys and bone marrow.
